Skip to main content

Branded

  • CDC: 9.3% of U.S. population has diabetes

    ATLANTA - More than 29 million people in the United States have diabetes, up from the previous estimate of 26 million in 2010, according to a report released Tuesday by the Centers for Disease Control and Prevention. One-in-four people with diabetes doesn’t know he or she has it.

  • FDA approves Strativa's Nascobal spray

    WOODCLIFF LAKE, N.J. — Strativa Pharmaceutical, a division of Par Pharmaceutical Cos., announced that the Food and Drug Administration approved Nascobal, a prescription B-12 supplement administered once a week as one spray.

  • New York approves cannabidiol trial in children diagnosed with epilepsy

    NEW YORK — New York Gov. Andrew Cuomo last week announced an agreement between New York State and GW Pharmaceuticals to develop clinical trials using an active ingredient derived from the marijuana plant to help treat children diagnosed with epilepsy who suffer from seizures and other medical complications. New York will be the second state in the nation to initiate trials for the extract, known as cannabidiol, for children whose medical conditions have not been successfully treated by other methods.

  • Study: Almost half of all narcotic prescriptions written by 5% of opioid prescribers

    SAN DIEGO — As many as 40% of U.S. narcotic prescriptions in 2011-2012 were written by only 5% of opioid prescribers, according to a study Express Scripts presented Monday at AcademyHealth's annual research meeting.

    The study identifies prescribers who prescribe opioids at a much higher rate than peers who are in the same specialty, treat patients of similar age and practice in the same geographic region. Express Scripts' multivariate approach to identifying high prescribers is the first of its kind, the company noted.

  • MMWR provides overview of 2013-14 influenza season, no change in flu shot composition

    ATLANTA — A report published Friday in the Morbidity and Mortality Weekly Report characterized the 2013-2014 influenza season as the first season since 2009 that H1N1 generated fewer levels of outpatient illness and mortality as compared with seasons when influenza A (H3N2) is predominant. 

    However, there were higher rates of hospitalization among adults ages 50 years to 64 years as compared to recent years, the report added. 

  • FDA approves BDSI's NDA for Bunavail

    RALEIGH, N.C. — BioDelivery Sciences International on Monday announced that the Food and Drug Administration approved its new drug application for Bunavail (buprenorphine and naloxone) buccal film (CIII). The drug is used as a maintenance treatment of opioid dependence. The company noted that it also should be used as part of a complete treatment plan to include counseling and psychosocial support.

    Bunavail is the first and only formulation of buprenorphine and naloxone for buccal (inside of the cheek) administration, BDSI said.

  • Government outlines what electronic health records should look like over next 10 years

    WASHINGTON — The Office of the National Coordinator for Health Information Technology last week issued a policy paper, "A 10-Year Vision to Achieve an Interoperable Health IT Infrastructure," which outlines the government's pledge to support interoperable electronic health records to most Americans. 

    America is three-quarters of the way there. 

  • Bayer HealthCare names Dieter Weinand president effective Aug. 1

    LEVERKUSEN, Germany — Bayer last week named Dieter Weinand president of Bayer HealthCare Pharmaceuticals effective Aug. 1. At that time, he also will join the executie committee of Bayer HealthCare. 

    "We welcome Dieter Weinand to our management team," said Olivier Brandicourt, Bayer HealthCare CEO. "Based on his extensive commercial experience in the pharmaceutical industry, Dieter Weinand will drive the growth of our pharmaceutical business further and maximize the value of our product portfolio." 

X
This ad will auto-close in 10 seconds